title: Should hydroxyethyl starch solutions be totally banned?
abstract: The choice of which intravenous solution to prescribe remains a matter of considerable debate in intensive care units around the world. Trends have been moving away from using hydroxyethyl starch solutions following concerns about safety. But are the available data sufficient to clearly assess the risk-benefit balance for all patients, and is there enough evidence of harm to justify removing these drugs completely from our hospitals?
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Vincent
authors.forename: John A
authors.initials: JA
authors.lastname: Kellum
authors.forename: Andrew
authors.initials: A
authors.lastname: Shaw
authors.forename: Michael G
authors.initials: MG
authors.lastname: Mythen
mesh_terms: D004348:Drug Labeling / Q000331:legislation & jurisprudence / Q000592:standards; D005440:Fluid Therapy / Q000009:adverse effects / Q000592:standards; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects* / Q000592:standards; D010952:Plasma Substitutes / Q000009:adverse effects* / Q000592:standards; D012307:Risk Factors
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes